CIK 0001054102 · Non-accelerated filer<br>Smaller reporting company
INTERPACE BIOSCIENCES, INC.
Sign in to watch- Ticker
- IDXG
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222919486
- Phone
- 412-224-6100
- Business address
- WATERVIEW PLAZA, SUITE 310, 2001 ROUTE 46, PARSIPPANY, NJ, 07054
- Former names
- Interpace Diagnostics Group, Inc., PDI INC, PROFESSIONAL DETAILING INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-15 | McCarthy Laurence Director | Grant or award · Series B Convertible Preferred Stock | +1,000 | $1,000.00 | $1.0M | 28,000 |
| 2020-01-15 | Lev Eric B. Director | Returned to the company · Series A Convertible Preferred Stock | +270 | 0 | ||
| 2020-01-15 | Lev Eric B. Director | Grant or award · Series B Convertible Preferred Stock | +27,000 | 27,000 | ||
| 2020-01-15 | Lev Eric B. Director | Grant or award · Series B Convertible Preferred Stock | +1,000 | $1,000.00 | $1.0M | 28,000 |
| 2020-01-15 | Ampersand 2018 Limited Partnership 10% owner | Returned to the company · Series A Convertible Preferred Stock | +270 | 0 | ||
| 2020-01-15 | Ampersand 2018 Limited Partnership 10% owner | Grant or award · Series B Convertible Preferred Stock | +27,000 | 27,000 | ||
| 2020-01-15 | Ampersand 2018 Limited Partnership 10% owner | Grant or award · Series B Convertible Preferred Stock | +1,000 | $1,000.00 | $1.0M | 28,000 |
| 2019-10-16 | Lev Eric B. Director | Grant or award · Series A Convertible Preferred Stock | +130 | $100,000.00 | $13.0M | 270 |
| 2019-10-16 | Ampersand 2018 Limited Partnership 10% owner | Grant or award · Series A Convertible Preferred Stock | +130 | $100,000.00 | $13.0M | 270 |
| 2019-10-10 | Lev Eric B. Director | Grant or award · Series A Convertible Preferred Stock | +80 | 140 | ||
| 2019-10-10 | Lev Eric B. Director | Returned to the company · Series A-1 Convertible Preferred Stock | −80 | 0 | ||
| 2019-10-10 | Ampersand 2018 Limited Partnership 10% owner | Grant or award · Series A Convertible Preferred Stock | +80 | 140 | ||
| 2019-10-10 | Ampersand 2018 Limited Partnership 10% owner | Returned to the company · Series A-1 Convertible Preferred Stock | −80 | 0 | ||
| 2019-03-13 | Freeburg Thomas John Chief Accounting Officer | Grant or award | +2,000 | 2,000 | ||
| 2019-03-13 | Freeburg Thomas John Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2019-03-13 | STOVER JACK E President and CEO | Grant or award | +86,922 | 427,300 | ||
| 2019-03-13 | STOVER JACK E President and CEO | Grant or award · Stock Option (right to buy) | +347,688 | 347,688 | ||
| 2019-03-13 | Richard Gregory Chief Commerical Officer | Grant or award | +39,528 | 84,169 | ||
| 2019-03-13 | Richard Gregory Chief Commerical Officer | Grant or award · Stock Option (right to buy) | +158,112 | 158,112 | ||
| 2019-03-13 | Early James Chief Financial Officer | Grant or award | +26,340 | 43,340 |
Page 4 of 8 · 158 trades